Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase II Study of Redefining The Use Of A FOLFIRINOX-Like Regimen In the Front Line In Older Patients With Metastatic Pancreatic Cancer

The purpose of this phase II trial is to evaluate the safety and tolerability of FOLFIRINOX in patients aged 65 and older with pancreatic cancer.

NCT#: NCT05360732
Study ID: GI-170
Trial Phase: Phase II

Trial Sponsor: Fox Chase Cancer Center
Therapies Used in This Trial: FOLFIRINOX

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Back to Trial Search